Quadron Cannatech Partners With Lucid Labs LLC.
Some friendly partnership news for the day... Quadron Cannatech Corporation (CSE:QCC) announced an agreement with Lucid Labs LLC. for industry-related extraction and processing systems. Commercial development of four new cannabis systems will soon begin in the North American region. The process will take place throughout the next 30 months. Furthermore, Quadron intends to make Lucid Labs a preferred sales agent for all processing systems and solutions in the Western United States.
Quadron deals in the ancillary cannabis market. They develop products and services and provide automated extraction and processing solutions. Their product line includes vape pens and capsules. Lucid Labs is an IP development and licensing company located in Washington State. Through various partnerships, they provide many technology-based solutions for the cannabis industry.
“Lucid Labs is excited to have entered into this agreement with Quadron,” company president Stephen Heimburger stated. “The combination of their high-level technical ability, and our extensive cannabis processing experience will result in equipment that is superior to anything currently available for the cannabis industry.”
Axim Biotech Sees Positive Results With CanChew +®
A possible medical breakthrough may have investors seeing green... On the research front, Axim Biotechnologies (OTCMKTS:AXIM) released results for its CanChew +® CBD functional, controlled release chewing gum. The product treats irritable bowel syndrome (IBS). Results from the first phase II pilot trial indicated toleration by patients with no adverse side-effects. The study, a randomized, placebo-controlled, double-blind, cross-over trial looked at patient acceptance and pain reduction. It took place at Wageningen University in The Netherlands,
Axim Biotech develops and produces cannabis-based pharmaceuticals, among other items. The company’s products include CanChew Plus™, CanChew+ 50™, and MedChew Rx™, all which are CBD-based. Research focuses on treating IBS, and pain and spasticity associated with multiple sclerosis.
“These results are highly encouraging,” said Professor Renger Witkamp who led the study at Wageningen University. “What we also learned from the analysis is that people are more likely to benefit from the product when they take a fixed daily dose instead of taking the chewing gum on perceived demand.”
Cann American Inks Exclusive Deal With Social Detention
Another day, another non-cannabis related company enters the market... Builder Social Detention Inc. (OTC PINK: SODE) inked an exclusive partnership deal with Cann American Holdings and Social subsidiary ELLA. Cann American will now use ELLA as their sole contractor for all construction projects. With legalization on the horizon in California, ELLA sought opportunities to use their government infrastructure knowledge in the cannabis market.
Cann American Holdings is a Sonoma County, California company. Their focus is on consulting grow operations in Northern California's Emerald Triangle region. The company relies on its client base to bring in contractors when it comes to building grow houses.
"We couldn't be more pleased with the opportunity to expand our footprint in a rapidly emerging industry allowing Social Detention Inc. to increase revenue and shareholder value," said Social Detention CEO Robert Legg.
Deals like this will bring cannabis stocks into the mainstream.
Around the Globe
From a land down under... PUF Ventures Inc. (CNSX:PUF) a biomedical ACMPR applicant brokered a deal with Dutch greenhouse builder KUBO for the construction of its Northern Rivers greenhouse project. Located in New South Wales, Australia, the Northern Rivers greenhouse plans to be Australia’s first “Ultra-Clima Greenhouse” dedicated to growing and cultivating cannabis. PUF, who counts Canopy Growth as a partner, has joined PUFA and MYM Nutraceuticals Inc. in the development of the greenhouse project.
From a land down under, part II... Queensland Bauxite (ASX:QBL), an Australian mining company with a hand in the medical cannabis sector, surged 40 percent on news of their purchase of a hemp seed processing plant. The medical cannabis division, aptly named Medical Cannabis Limited, has a hemp seed food business named VitaHemp. The deal has VitaHemp purchasing 55 percent of Hemp Hulling, a company called “Australia’s best hemp seed processing and innovation group”.
And in South American news... AusCann Group Holdings Ltd. (ASX:AC8) has now secured a second cultivation license for another medical cannabis crop. The license comes through the company’s 50:50 joint venture in Chile, with a group named DayaCann. It is a one-of-a-kind license granted in Chile which allows for the company to begin cultivation activity. DayaCann is the sole licensed producer in Chile.
News and Notes
A rose by any other name... As noted yesterday, IC Potash Corp. (TSX:ICP)(OTCQB:ICPTF) is delisting from the Toronto Stock Exchange to trade on the Canadian Securities Exchange on November 23. Accompanying the move, which occurs at close of business today the company will officially change its name from IC Potash Corp. to Belgravia Capital International Inc. The newly named company will continue to focus on the fertilizer and medical cannabis sectors.
And in stocks to watch… Investors took notice of GW Pharmaceuticals (NASDAQ:GWPH) yesterday as the stock jumped 11.1 percent during trading. The excitement came on the news of positive results in trials of the drug Epidiolex, which is designed to reduce seizures in rare forms of epilepsy. There are still hoops to jump through with both the FDA and the DEA, but experts say investors are right to be excited by the drug results.